Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Phoilex Active ReLeaf Spot Gel Wins 2025 SHAPE Skin Award for "Best for Flare Ups" Clinically-Proven, Steroid-Free Eczema, Psoriasis & Itch Relief


News provided by

Phoilex

Jun 11, 2025, 16:00 ET

Share this article

Share toX

Share this article

Share toX

Active ReLeaf Spot Gel
Active ReLeaf Spot Gel

Phoilex Active ReLeaf Spot Gel wins 2025 SHAPE Skin Award for "Best for Flare Ups" with its clinically-proven, steroid-free formula that calms eczema, psoriasis, and TSW—fast.

NEW YORK, June 11, 2025 /PRNewswire-PRWeb/ -- Phoilex, the science-backed, steroid-free skincare brand for chronic skin conditions, proudly announces that its award-winning eczema and psoriasis treatment, Phoilex Active ReLeaf Spot Gel, has been named the winner of the 2025 SHAPE Skin Award for Best Flare Ups. This meaningful recognition from Shape magazine recognizes Phoilex's deep commitment to offering clinically proven, plant-based solutions for eczema, psoriasis, Topical Steroid Withdrawal Syndrome (TSW), and rash-prone skin.

Why Phoilex Active ReLeaf Spot Gel is a Game-Changer for Skin Flare-Ups:

"This accolade is a testament to our dedication to developing effective, non-steroidal alternatives for individuals battling the discomfort of eczema, psoriasis, and hypersensitive skin." - Sarina Pilaroscia, Founder

Post this

The annual Shape Skin Awards are renowned for their rigorous testing process, evaluating hundreds of skincare products. Selections are guided by an expert panel including dermatologists, plastic surgeons, formulators and beauty/health editors. This award underscores Active ReLeaf Spot Gel's exceptional efficacy and innovation in rapidly calming and soothing skin flare-ups.

"This accolade is a testament to our dedication to developing effective, non-steroidal alternatives for individuals battling the discomfort of eczema, psoriasis, and hypersensitive skin. To have Shape's expert panel recognize the profound itch relief and flare reduction our gel provides is truly validating, especially as our product was born from a personal journey to soothe my father's chronic skin discomfort from psoriasis and Topical Steroid Withdrawal (TSW)," states Sarina Pilaroscia, Founder of Phoilex.

Key Features & Benefits for Sensitive Skin:

Phoilex Active ReLeaf Spot Gel is a breakthrough over-the-counter eczema, psoriasis and itch relief gel specifically formulated to:

  • Calm Irritated Skin: Provides fast-acting relief for burning, itchy, and inflamed skin
  • Reduce Flare-Ups: Helps to prevent and diminish the severity of skin flares
  • Restore Skin Barrier: Supports overall skin health and resilience

Clinically Proven Results:

A study published in the peer-reviewed journal, Dermatological Review, highlights the gel's impressive efficacy:

  • 93% of users experienced relief from itchy skin for 4-12 hours
  • 74% of users reported a significant reduction in flare-ups after 8 weeks of use
  • 73% of participants experienced immediate itch relief after the first week of use

Science-Backed Ingredients for Optimal Skin Health:

The proprietary Phoilex Phyto-Active Blend™ harnesses the power of nature's finest ingredients, each carefully selected for its specific benefits for sensitive skin. Additional ingredients include:

  • Ceramide Complex: Essential for skin barrier repair and maintaining crucial moisture
  • Triple Vitamin D3 Complex: Offers potent anti-inflammatory and antioxidant benefits, promoting skin cell regeneration
  • Hemp-Derived CBD: A powerful anti-inflammatory for dry, itchy skin relief and reduced irritation
  • 4% Colloidal Oatmeal: A time-tested ingredient that soothes stressed skin and aids in healing
  • Bisabolol, Emu Oil, and Skullcap Extract: Further enhance the gel's soothing, anti-inflammatory, and restorative properties

Addressing Topical Steroid Withdrawal (TSW):

As a proud sponsor of the International Topical Steroid Awareness Network (ITSAN), Phoilex is dedicated to raising awareness about Topical Steroid Withdrawal (TSW ), a debilitating condition that can develop from prolonged use of topical steroids. Phoilex offers a safe, non-steroidal alternative for individuals seeking to avoid or recover from this painful condition. As Kelly Barta, president of ITSAN, described to Women's Health, TSW felt "as though someone had poured boiling water over me," underscoring the need for gentler, effective solutions like Phoilex.

Availability: Phoilex Active ReLeaf Spot Gel (60 ML, $58) is available exclusively at Phoilex.com.

Learn More About the Shape Skin Awards: Discover all the winners and insights at Shape.com/shape-skin-awards-2025-11732904.

About Phoilex: Phoilex is a clinically-proven, steroid-free wellness brand committed to transforming skin health for individuals battling chronic eczema, atopic dermatitis, psoriasis, and hypersensitive skin. Founded by Sarina Pilaroscia, whose personal eczema journey and her father's struggle with psoriasis and Topical Steroid Withdrawal inspired the brand. Phoilex offers gentle and powerful plant-based alternatives to traditional steroidal treatments. With a dedication to science-backed formulations, ethical sourcing, and community support, Phoilex empowers individuals to achieve lasting comfort and confidence.

Join the #PHOILEXFAM Community: Follow us on Instagram: @phoilex.releaf

Media Contact

Charity Guzofski, RED PR, 1 201-264-0700, [email protected], www.red-pr.com

SOURCE Phoilex

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.